Form 4: Hagerty Inc. Director Robert Kauffman Executes Stock Sales Under 10b5-1 Plan
SEC Form 4
Director Robert Kauffman sold shares of Hagerty, Inc. (HGTY) on May 13 and 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Robert Kauffman, a director of Hagerty, Inc. (HGTY), executed sales of Class A Common Stock on May 13 and May 14, 2024.
- The sales were conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
- On May 13, 2024, 2,008 shares were sold at a weighted average price of $9.03, with prices ranging from $9.00 to $9.09.
- On May 14, 2024, 597 shares were sold at a weighted average price of $9.02, with prices ranging from $9.00 to $9.05.
- Following these transactions, Kauffman indirectly owns 3,397,555 shares through Aldel LLC, where he serves as manager and has voting and investment discretion.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock sales under a pre-arranged plan. There's no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of stock sales by a company insider. It's common for executives and directors to use 10b5-1 plans to sell shares over time to avoid accusations of insider trading. The impact on the stock depends on the size of the sales relative to the overall trading volume and investor sentiment.
Comparison to Industry Standards
- Comparing these transactions to similar filings from directors at comparable companies in the insurance or automotive enthusiast space would provide context.
- For example, reviewing Form 4 filings from executives at companies like Progressive, Geico, or even niche automotive marketplaces could offer a benchmark for insider trading activity.
- Analyzing the size and frequency of these sales relative to the director's overall holdings and the company's trading volume is crucial for assessing the significance of these transactions.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders if they perceive it as a lack of confidence from the director, although the 10b5-1 plan mitigates this concern.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/13/2024 | Date of first stock sale |
| 05/14/2024 | Date of second stock sale |
| 05/15/2024 | Date of signature by Power of Attorney |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.